share_log

富士莱(301258.SZ):暂无细胞免疫治疗方面的布局

Fujilai (301258.SZ): No plans for cellular immunotherapy

Gelonghui Finance ·  May 10 03:33

Gelonghui, May 10 | Fujilai (301258.SZ) said on the investor interactive platform that the company has no plans for cellular immunotherapy yet.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment